Ashok Boob to become vice chairman; Siddhartha Sikchi to become MD

Management Changes View source PDF Explain this filing

CLEAN · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close

-0.2%Reaction day

₹985.50

prior close

₹969.50

announcement price

In-mkt

timing

Nifty Smallcap 250market · index membership as recorded later (tracked since Jun 2026)-1.5%+1.3% vs market

Specialty Chemicals peers, median of 83sector-1.4%+1.3% vs sector

On the reaction day the stock moved 1.3 pts more than Nifty Smallcap 250 and 1.3 pts more than its Specialty Chemicals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark

Stock

-0.1

10m

-0.1

15m

+1.0

30m

+1.3

Sessions after the filingfrom the prior close

StockMarketvs marketSectorvs sector

Reaction day

-0.2-1.5+1.3-1.4+1.3

Next day

-5.1-1.7-3.4-1.6-3.5

-4.9-1.7-3.1-2.7-2.1

-5.9-1.9-4.1-3.4-2.6

-4.2-1.2-3.1-1.6-2.6

-4.6-1.6-3.1-2.1-2.5

-5.1-0.7-4.4-3.7-1.5

15d

-6.8-3.2-3.6-6.9+0.1

-9.9-6.9-3.0-10.0+0.1

-12.1-3.1-9.1-11.6-0.5

-19.2-8.4-10.8-14.2-5.1

UpDownMarket · Nifty Smallcap 250Sector · Specialty Chemicals peers, median of 83Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

The board approved Q2 results: consolidated revenue was Rs 214.6 crore and net profit Rs 77.36 crore; first-half revenue was Rs 390.55 crore and net profit Rs 108.16 crore. Subject to shareholder approval, Ashok Boob will become executive vice chairman on 1 April 2026, while Siddhartha Sikchi will become managing director.

Likely market impact

The planned succession keeps promoter Boob involved while shifting management to Sikchi. It may support continuity, but shareholder approval is pending.